ArticleDisease markers2022

Construction of a Humanized PBMC-PDX Model to Study the Efficacy of a Bacterial Marker in Lung Cancer Immunotherapy.

Chengwei Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.